Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Cash from Financing Activities (2017 - 2025)

Neuronetics (STIM) has disclosed Cash from Financing Activities for 9 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 110.76% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.8 million through Dec 2025, up 12.87% year-over-year, with the annual reading at $35.8 million for FY2025, 626.59% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$1.0 million at Neuronetics, down from $17.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $82.2 million in Q1 2021, with the low at -$1.0 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $10.1 million, with a median of $245000.0 recorded in 2022.
  • Peak annual rise in Cash from Financing Activities hit 8985.71% in 2023, while the deepest fall reached 720.0% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $32000.0 in 2021, then skyrocketed by 665.62% to $245000.0 in 2022, then surged by 8985.71% to $22.3 million in 2023, then tumbled by 57.04% to $9.6 million in 2024, then tumbled by 110.76% to -$1.0 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$1.0 million, $17.9 million, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.